Partner Nate Lacktman was quoted in a CNBC article, “How men’s health start-ups are turning erectile dysfunction and hair loss treatment into a booming business,” about an emerging class of start-ups that blend traditional e-commerce, subscription services and health care to provide customers with the products they need while avoiding undesirable trips to a doctor.
Lacktman, who chairs the firm’s national Telemedicine & Digital Health Industry Team, said the companies are not only taking advantage of a friendlier regulatory environment, but are also getting smarter about making sure that remote treatment is appropriate for the specific conditions they’re targeting, so they’re not perceived as a “pill mill.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”